Question 87

Janumet and Eliquis should generate an alert in a pharmacy computer system.

Both Janumet, which is used to manage blood sugar in type 2 diabetes, and Eliquis, an anticoagulant, can have significant interactions that necessitate monitoring to avoid adverse effects. Thus, an alert is warranted when these medications are processed for the same patient.

A) Janumet and Eliquis

This pair should generate an alert because combining these medications can increase the risk of bleeding complications while managing diabetes. The interactions between diabetes medications and anticoagulants require careful monitoring, making this combination critical for alert generation.

B) Lasix and Crestor

Lasix (a diuretic) and Crestor (a statin) do not have significant interactions that would necessitate an alert in most cases. While both medications serve different purposes, their concurrent use is typically considered safe without major concerns for adverse effects.

C) Pepcid and Claritin

Pepcid, a medication for reducing stomach acid, and Claritin, an antihistamine, can be used together without significant interaction risks. Therefore, there is no need for an alert when processing these medications for the same patient, as they are generally safe to combine.

D) Cortef and Premarin

Cortef (a corticosteroid) and Premarin (an estrogen replacement therapy) do not generally interact in a way that would require an alert. While both medications can have side effects, their combination is often tolerated without significant risk, thus not warranting an alert in a pharmacy system.

Conclusion

In summary, Janumet and Eliquis necessitate an alert due to their potential interactions that could lead to serious health risks. The other options either lack significant interaction concerns or are generally safe to use together, highlighting the importance of critical monitoring in medication management.